Praxis a new buy at BTIG as biotech is a top pick for 2026
Source: SeekingAlpha
2025-11-19 12:19:13 ET
More on Praxis Precision Medicines
- Praxis: Back From The Dead, Ulixacaltamide Returns In Essential Tremor With Caveats
- Praxis Precision Medicines, Inc. (PRAX) Discusses Essential3 Topline Results and Next Steps in Essential Tremor Program Transcript
- Praxis Precision Medicines, Inc. (PRAX) Discusses Essential3 Topline Results and Next Steps in Essential Tremor Program - Slideshow
- Praxis speeds up R&D plans for seizure therapy after FDA feedback
- Praxis Precision Medicines prices $525M public offering
Read the full article on Seeking Alpha
For further details see:
Praxis a new buy at BTIG as biotech is a top pick for 2026
Praxis Precision Medicines Inc.
NASDAQ: PRAX
PRAX Trading
2.09% G/L:
$303.865 Last:
94,924 Volume:
$301.46 Open:
PRAX Latest News
March 13, 2026 10:34:56 am
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline
March 13, 2026 09:43:25 am
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
March 09, 2026 09:54:00 am
Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment
March 04, 2026 04:01:00 pm
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRAX Stock Data
$8,057,264,446
20,105,683
0.7%
83
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
